← Browse by Condition
Medical Condition
primary cutaneous t cell non hodgkin lymphoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT04930653 Phase 2
Recruiting
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Enrollment
34 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT07356245 Phase 2
Recruiting
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Enrollment
44 pts
Location
United States
Sponsor
Jonathan Brammer